查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198538

外科影像市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Surgical Imaging Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计手术影像市场在预测期内的复合年增长率为 6.1%。

在 COVID-19 流行初期，对污染风险的担忧显着减少了全球提供的医学成像服务的数量，以及放射性示踪剂等某些成像剂的供应不足。这对市场增长产生了重大影响。 例如，根据 2021 年 11 月在 PubMed 上发表的一篇论文，COVID-19 流行病显着减少了放射成像和程序。 放射服务的总体下降取决于锁定阶段/持续时间、位置和成像方式。 同一消息来源报告称，超声检查减少了 76%，MRI 检查减少了 74%，乳房 X 光检查减少了 66%。 然而，在后疫情形势下，随着限制解除，手术影像技术的进步和慢性病诊断影像的需求，市场需求正在增加。

在过去十年中，需要进行严重诊断的多种慢性病的患病率有所增加。 外科重症监护病房的患者经常接受实验室和影像学检查。 特别是一些慢性病，如高血压、糖尿病、肥胖症和抑郁症，在住院期间需要重症监护。 预计心血管疾病的高患病率将增加对外科影像服务的需求，从而推动市场增长。 例如，根据 BHF 的 2022 UK Factsheet，截至 2022 年 8 月，英国有超过 760 万人患有心脏病和心血管疾病。 资料单显示，心脏病和心血管疾病每年花费超过 90 亿欧元（76 亿美元）。 此外，受心血管疾病影响的大量人口以及随之而来的高额年度医疗费用预计将在预测期内推动研究市场的增长。 慢性阻塞性肺病 (COPD) 是一种呼吸系统疾病，是肺部的慢性炎症，会抑制肺部的气流。 这种疾病通常在胸部 X 光、CT 和磁共振成像 (MRI) 的帮助下诊断。 据英国下议院2021年11月发布的一份调查报告显示，英国有超过117万人被诊断患有慢性阻塞性肺病，约占人口的1.9%。 受 COPD 影响的庞大人口将增加对手术影像服务的需求，以进行适当的治疗和管理，从而推动预测期内的市场增长。

此外，与手术成像领域相关的产品发布、竞争对手的存在、併购可能会在预测期内推动市场增长。 例如，2022 年 7 月，西门子 Healthineers 宣布推出 ARTIS icono ceiling，这是一种吊顶式 C 臂血管造影系统，专为介入放射学 (IR) 和心脏病学的广泛常规和高级程序而设计，并获得了 FDA 的批准。 此外，2022 年 4 月，医疗技术和数字解决方案的创新者 Wipro GE Healthcare 推出了下一代 CT（计算机断层扫描）扫描仪 Revolution Aspire。 Revolution Aspire 是根据“Atmanirbhar Bharat”倡议在新启动的 Wipro GE 医疗设备製造厂中端到端设计和製造的。 因此，与手术影像领域相关的此类产品的推出有望在预测期内推动市场增长。

因此，由于慢性病的增加和对微创手术的需求增加，预计手术成像市场在预测期内将会增长。 然而，高昂的程序和设备成本以及严格的监管准则预计将限制预测期内的市场增长。

外科影像市场趋势

手术影像市场预计在预测期内移动 C 臂部分将快速增长

移动式 C 臂是一种使用 X 射线技术的医学成像设备，可用于诊所内的各种手术室。 它源于连接X射线源和X射线探测器的C形臂。 C 形臂的一大优势是它可以在患者周围移动以获得最佳角度，以获得高图像质量和患者舒适度。 这使其成为成本受限的小型医院的理想选择。

慢性病患病率上升和微创手术需求增加等因素似乎正在推动市场增长。 例如，根据 Blast Cancer.org 的 2022 年更新，美国约有 13%（约八分之一）的女性可能在 2022 年患上浸润性乳腺癌。 根据同一消息来源，估计到 2022 年，美国女性将诊断出 287,850 例浸润性乳腺癌新病例，以及 51,400 例非浸润性（原位）乳腺癌新病例。 因此，越来越多的慢性病例将增加对移动 C 型臂的需求，这将推动预测期内的市场增长。

此外，移动 C 臂领域主要参与者的存在、併购和产品发布可能会在预测期内推动市场增长。 例如，2022 年 1 月，Philips将基于云的人工智能和 3D 映射集成到其移动 C 臂系统系列“Zenition”中，以简化工作流程并改善血管内治疗结果。 此外，2021 年 6 月，Turner Imaging Systems 的便携式荧光透视 X 射线成像设备“Smart-C Mini C-Arm”获得了 CE 标誌。 因此，预计Smart-C这种具有出色便携性的迷你C臂不仅可以在英国销售，还可以在欧盟国家销售。

因此，由于慢性病的增加和对微创手术的需求不断增长，预计移动 C 臂细分市场将在预测期内实现显着增长。

北美将占据很大的市场份额，预计在预测期内也会如此

由于慢性病和遗传病患病率上升、医疗保健基础设施和缺乏报销等因素，预计北美的手术影像市场将出现增长。 例如，根据美国癌症协会的 2022 年更新，2022 年美国将诊断出 1,918,030 例新的癌症病例。 根据同一消息来源，2022 年美国将诊断出 268,490 例前列腺癌病例。 因此，由于慢性病的高患病率，预计对手术成像的需求将增加，这有望在预测期内推动市场增长。

此外，微创手术的需求正在上升，预计在预测期内将推动研究区域的市场增长。 例如，2022年5月，TRiCares在加拿大推出微创Topaz三尖瓣置换系统。 此外，2021 年 5 月，KA Imaging 宣布已与 Bio Scan S.A. de C.V.签署墨西哥分销协议。 作为墨西哥的总销售代理，Bio Scan 将与 KA Imaging 全面合作，提供销售和支持。

此外，与手术成像领域相关的竞争对手的存在、产品发布和批准预计将在预测期内推动市场增长。 例如，2021 年 12 月，经 FDA 批准的便携式磁共振成像 MRI 机器 Swoop 的创建者 Hyperfine, Inc. 在成像系统在加拿大商业发布的同时获得了加拿大卫生部的 Swoop 许可。 此外，2021 年 2 月，南岸地区医院重建项目将开始，政府将资助南岸地区医院安装新的磁共振成像 (MRI) 扫描仪。

因此，由于慢性病的高患病率和对手术成像的需求不断增加，所研究的市场在预测期内可能会在北美地区出现增长。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 对微创手术的需求不断扩大
    • 慢性病负担加重
  • 市场製约因素
    • 高昂的手术和设备费用
    • 严格的监管准则
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第五章市场细分（价值基础，单位：百万美元）

  • 通过成像技术
    • 磁共振成像
    • 计算机断层扫描
    • C型臂
      • 固定式 C 型臂
      • 移动式 C 型臂
    • 超声诊断设备
    • 其他图像处理技术
  • 通过申请
    • 心臟外科、血管外科
    • 神经外科
    • 整形外科/外伤外科
    • 消化外科
    • 其他应用
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Canon Medical Systems Corporation
    • General Electric Company（GE Healthcare）
    • Geonoray Co. Ltd
    • Hologic Inc.
    • Koninklijke Philips NV
    • Medtronic plc
    • Orthoscan Inc.
    • Seimens AG
    • Shimadzu Corporation
    • Ziehm Imaging

第七章市场机会与未来趋势

简介目录
Product Code: 60444

The surgical imaging market is expected to register a CAGR of 6.1% over the forecast period.

During the initial phase of the COVID-19 pandemic, there was a severe reduction in the number of medical imaging services provided all over the world, owing to the fear of the risk of contamination, and the non-availability of certain imaging agents, such as radiotracers, which heavily impacted the growth of the market. For instance, as per the article published in November 2021 in PubMed, the COVID-19 epidemic resulted in a considerable decrease in radiology imaging and procedures. The overall reduction in radiology services was determined by the stage/period of lockdown, location, and imaging modality. As per the same source, a 76% reduction in ultrasound, 74 % reduction in MRI, and 66% reduction in mammography were reported. However, in the post-pandemic situation, as the restrictions are lifted, the market is gaining demand due to the advancements in surgical imaging techniques and the need for diagnostic imaging for chronic diseases.

Over the last decade, there has been a rise in the prevalence of several chronic diseases that need critical care diagnosis. The patients in the surgical intensive care unit frequently undergo laboratory and imaging testing. Several chronic diseases, such as hypertension, diabetes, obesity, and depression, amongst others, need critical care during their hospitalizations. The high prevalence of cardiovascular disorders is expected to boost the demand for surgical imaging services, thereby propelling the market growth. For instance, according to the 2022 UK Factsheet by BHF, over 7.6 million people in the United Kingdom were living with heart and circulatory diseases as of August 2022. The factsheet indicated that heart and circulatory diseases cost the nation over EUR 9 billion (USD 7.6 billion) every year. Moreover, the large population affected by cardiovascular diseases along with the associated high annual healthcare costs are expected to boost the growth of the studied market over the forecast period. Also, chronic obstructive pulmonary disease (COPD), a type of respiratory disease is chronic inflammation in the lungs that causes obstructed airflow from the lungs. The disease is generally diagnosed with the help of chest X-ray, CT, and magnetic resonance imaging (MRI). According to the research briefing by the United Kingdom House of Commons published in November 2021, there were over 1.17 million people in England who had been diagnosed with COPD, accounting for around 1.9% of the population. The huge population affected by COPD increases the demand for surgical imaging services for proper therapy and management, thereby propelling market growth over the forecast period.

Furthermore, product launches, the presence of competitors, mergers, and acquisitions relating to the surgical imaging field are likely to boost the market growth over the forecast period. For instance, in July 2022, Siemens Healthineers received approval from the FDA for the ARTIS icono ceiling, a ceiling-mounted C-arm angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology. Furthermore, in April 2022, Wipro GE Healthcare, a medical technology, and digital solutions innovator launched its next-generation Revolution Aspire CT (Computed Tomography) scanner. Revolution Aspire is designed and manufactured end-to-end in India, at the newly launched Wipro GE Medical Devices Manufacturing plant, in line with the 'Atmanirbhar Bharat' initiative. Hence, such product launches associated with the surgical imaging field are likely to boost market growth over the forecast period.

Hence, due to the rise in chronic diseases and the increase in demand for minimally invasive procedures, the market for surgical imaging is anticipated to grow over the forecast period. However, the high procedural and equipment costs and the stringent regulatory guidelines are expected to restrict the market growth during the forecast period.

Surgical Imaging Market Trends

Mobile C-Arm Segment is Believed to Witness Rapid Growth Over the Forecast Period in the Surgical Imaging Market

A mobile C-arm is a medical imaging device that uses X-ray technology and can be utilized in a variety of operation rooms across a clinic. The term is derived from the C-shaped arm that connects the X-ray source and X-ray detector. One of the major advantages of C-arms is the ability to move around the patient for achieving the optimum angle for a high-quality image while keeping the patient comfortable. These factors are ideal for smaller hospitals with significant cost constraints.

Factors such as the rise in the prevalence of chronic diseases, and growing demand for minimally invasive procedures are likely to boost the market growth. For instance, as per the 2022 update from Brast Cancer.org, about 13% (about 1 in 8) of U.S. women are likely to develop invasive breast cancer in 2022. As per the same source, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive (in situ) breast cancer. Hence, as the number of chronic cases increases, the demand for mobile C-arm rises and thereby boosting the market growth over the forecast period.

Moreover, the presence of key players, mergers, acquisitions, and product launches in the mobile C-arm field is likely to boost the market growth over the forecast period. For instance, in January 2022, Philips integrated cloud-based artificial intelligence and 3D mapping into its Mobile C-arm System Series, Zenition, to enhance workflow efficiency and improve endovascular treatment outcomes. Furthermore, in June 2021, Turner Imaging Systems received its CE Mark for its Smart-C Mini C-Arm portable fluoroscopy X-ray imaging device. This was anticipated to allow the Smart-C, a highly portable mini C-arm, to be distributed throughout the EU countries as well as the UK.

As a result, due to the rise in the prevalence of chronic diseases, and the growing demand for minimally invasive procedures, the mobile c-arm segment is expected to register significant growth during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to witness growth in the surgical imaging market owing to the factors such as the rising prevalence of chronic diseases and genetic disorders as well as the presence of healthcare infrastructure and reimbursement availability. For instance, as per the American Cancer Society 2022 update, the number of new cancer cases diagnosed in the United States is likely to be 1,918,030 in 2022. As per the same source, 268,490 cases of prostate cancer are likely to be diagnosed in the United States in 2022. Hence, due to the high prevalence of chronic disease, there is likely to be a rise in demand for surgical imaging, which is anticipated to boost market growth over the forecast period.

Moreover, the demand for minimally invasive procedures is on the rise, which is anticipated to boost the market growth in the studied region over the forecast period. For instance, in May 2022, TRiCares implemented of minimally invasive Topaz Tricuspid Heart Valve replacement system in Canada. Furthermore, in May 2021, KA Imaging announced a distribution agreement with Bio Scan S.A. de C.V. in Mexico. Bio Scan, as the sole distributor in Mexico, the company was likely to be responsible for sales and support in full collaboration with KA Imaging territory-wide.

Additionally, the presence of competitors, product launches, and approvals associated with the surgical imaging field is likely to drive market growth over the forecast period. For instance, in December 2021, Hyperfine, Inc., creator of the FDA-cleared portable magnetic resonance imaging MRI device, Swoop received Health Canada licensing of Swoop as well as the commercial launch of the imaging system in Canada. Furthermore, in February 2021, South Shore Regional Hospital Redevelopment Project was launched under which the government has funded a new Magnetic Resonance Imaging (MRI) scanner for the South Shore Regional Hospital.

Thus, due to the high prevalence of chronic diseases and the rise in demand for surgical imaging, the studied market is likely to witness growth in the North America region over the forecast period.

Surgical Imaging Market Competitor Analysis

The surgical imaging market is moderately competitive and consists of several global players. As the market is progressing, the firms are trying to achieve clear differentiation in surgical imaging systems, based on their application. Due to the requirements for high-quality imaging and operative capabilities, various customer groups are shifting toward optimized surgical imaging systems. Major players are Canon Medical Systems Corporation, Medtronic Plc, Hologic Inc, and General Electric Company (GE healthcare) among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand of Minimally Invasive Procedures
    • 4.2.2 Growing Burden of Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Procedural and Equipment Costs
    • 4.3.2 Stringent Regulatory Guidelines
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Imaging Technology
    • 5.1.1 Magnetic resonance imaging
    • 5.1.2 Computed Tomography
    • 5.1.3 C-Arm
      • 5.1.3.1 Fixed C-Arm
      • 5.1.3.2 Mobile C-Arm
    • 5.1.4 Ultrasound
    • 5.1.5 Other Imaging Technologies
  • 5.2 By Application
    • 5.2.1 Cardiac and Vascular Surgery
    • 5.2.2 Neurosurgery
    • 5.2.3 Orthopedic and Trauma Surgery
    • 5.2.4 Gastrointestinal Surgery
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems Corporation
    • 6.1.2 General Electric Company (GE Healthcare)
    • 6.1.3 Geonoray Co. Ltd
    • 6.1.4 Hologic Inc.
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 Medtronic plc
    • 6.1.7 Orthoscan Inc.
    • 6.1.8 Seimens AG
    • 6.1.9 Shimadzu Corporation
    • 6.1.10 Ziehm Imaging

7 MARKET OPPORTUNITIES AND FUTURE TRENDS